KCT0003152
Recruiting
未知
Brain monitoring for high risk of brain metastases in metastatic breast cancer
ConditionsNeoplasms
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Neoplasms
- Sponsor
- Yonsei University Health System, Severance Hospital
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Age \= 19 years old
- •2 Histologically or cytologically confirmed recurrent / metastatic breast cancer patients
- •3 Breast cancer subtype that meets one of the following criteria:
- •A. HER2 positive patients regardless of hormone receptor status or
- •B. triple\-negative breast cancer patients
- •4 Patients scheduled to undergo systemic chemotherapy
- •5 Patients who adhere to the study protocol during the clinical study period. Patients with signed consent by themseleves or their legal guardians who understand that they have the right to withdraw their consent at any time without penalty.
Exclusion Criteria
- •1\. History of prior treatments about brain metastases or leptomengeal metastases
- •2\. Symptomatic brain metastases at screening period
- •3\. Has received more than second\-line systemic treatments (including endocrine therapy)
- •4\. For subjects who have difficulty lying down or who have claustrophobia, they can undergo sedation during brain MRI
- •5\. Patients with history of hypersensitivity reaction to contrast or antibiotics (e.g. penicilin, ampicilin), history of kidney disease, or impaired kidney function
- •6\. Patietns who inserted metallic prothesis (pacemaker, denture, hearing aid, anurysm clip, metallic material of eyeball, artifical joint, insulin pump, chemoport, temporary tissue expander for breast reconstruction, etc) can be conducted after consultation with investigator before MRI.
- •7\. Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.
- •8\. Participants who are sure to be excluded from this study or who can not be regular follow\-up because of the following reasons:
- •For example, Social, familial, or geographical factors that would interfere with study participation or follow\-up
- •9\. In addition, participants who the investigator deems inappropriate for this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
Brain Monitoring for High Risk of Brain Metastases in Metastatic Breast CancerMetastatic Breast Cancer With HER2 PositiveTriple Negative Breast CancerNCT03617341Yonsei University200
Recruiting
Not Applicable
Screening op hersenmetastasen bij niet kleincellig longkanker: de psychologische impact van de diagnose asymptomatische hersenmetastasen; een focus groep onderzoekNL-OMON28792MUMC18
Recruiting
Not Applicable
MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast CancerBreast CancerNCT06247449Sunnybrook Health Sciences Centre100
Unknown
Phase 2
A Phase II Multi-center Pilot Study of Concurrent Temozolomide and Whole Brain Irradiation in Lung Cancer and Breast Cancer Patients With Brain MetastasesLung Cancer and Breast Cancer Patients With Brain MetastasesNCT02133677Far Eastern Memorial Hospital24
Active, not recruiting
Not Applicable
Prospective Double Arm Randomized Trial: WBRT Alone and WBRT Plus SilibininBrain Metastases, AdultNCT05793489Istituto Clinico Humanitas44